MidFirst Bank’s ResMed RMD Stock Holding History

MidFirst Bank’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.29K	Hold	22	–	–	﹤0.01%	603
2026 Q1	$4.94K	Buy	+22	New	+$5.48K	﹤0.01%	580

Other funds holding RMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

MidFirst Bank's RMD Position: Q2 2026 in Review

MidFirst Bank held its ResMed (RMD) position steady in Q2 2026 at 22 shares worth $4.29K. The position accounts for ﹤0.01% of the portfolio, ranked #603.

MidFirst Bank first reported a position in RMD in Q1 2026 and has held it in 2 quarters since. The position peaked at $4.94K in Q1 2026. 891 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

MidFirst Bank held 22 shares of ResMed worth $4.29K as of Q2 2026.
MidFirst Bank left its ResMed share count unchanged in Q2 2026.
ResMed made up ﹤0.01% of MidFirst Bank's portfolio in Q2 2026, its #603 holding.
MidFirst Bank first reported a position in ResMed in Q1 2026 and has held it in 2 quarters since.
MidFirst Bank's ResMed position peaked at $4.94K in Q1 2026.
891 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on MidFirst Bank's 13F filing for Q2 2026, filed 7 Aug 2026.